The EU drugs agency (EMCDDA) launches its European Drug Report 2020: Trends and Developments in a live online media event on 22 September.
In this latest annual review – marking 25 years of monitoring – the EMCDDA describes the drug situation at the end of 2019, along with recent changes brought by the COVID-19 pandemic in early 2020.
The report provides a comprehensive analysis of patterns emerging across the EU, Turkey and Norway in the areas of drug supply, illicit drug use and associated public health problems. National data sets are also provided across these themes and on key harm-reduction interventions. In a new format, chapters are organised primarily by drug type and by related harms.
Accompanying the report this year will be a Key Issues summary (in 24 languages), presenting a selection of the main findings from the latest analysis, chosen for their policy relevance and general interest. The 2020 Statistical Bulletin, containing the European dataset underpinning the report, will also be available.
Attend the live online media event to hear the key issues and latest analysis on 22 September 2020 at 10.00 (Lisbon), 11.00 CET.
Further details will be available in the run-up to the launch at: www.emcdda.europa.eu/edr2020.